| New insights into the cancer–microbiome–immune axis: decrypting a decade of discoveries T Jain, P Sharma, AC Are, SM Vickers, V Dudeja Frontiers in immunology 12, 622064, 2021 | 108 | 2021 |
| Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma: an update on heterogeneity and therapeutic targeting U Vaish, T Jain, AC Are, V Dudeja International journal of molecular sciences 22 (24), 13408, 2021 | 64 | 2021 |
| The war against pancreatic cancer in 2020—advances on all fronts T Jain, V Dudeja Nature reviews Gastroenterology & hepatology 18 (2), 99-100, 2021 | 47 | 2021 |
| Pirfenidone increases IL-10 and improves acute pancreatitis in multiple clinically relevant murine models EP Bava, J George, M Tarique, S Iyer, P Sahay, BG Aguilar, DB Edwards, ... JCI insight 7 (2), 2022 | 14 | 2022 |
| Hsp70 modulates immune response in pancreatic cancer through dendritic cells B Giri, P Sharma, T Jain, A Ferrantella, U Vaish, S Mehra, B Garg, S Iyer, ... Oncoimmunology 10 (1), 1976952, 2021 | 11 | 2021 |
| Pirfenidone ameliorates chronic pancreatitis in mouse models through immune and cytokine modulation EP Bava, J George, S Iyer, P Sahay, M Tarique, T Jain, U Vaish, B Giri, ... Pancreatology 22 (5), 553-563, 2022 | 9 | 2022 |
| Prescription patterns of pancreatic enzyme replacement therapy for patients with pancreatic cancer in the United States T Jain, P Sharma, B Giri, S Iyer, V Sethi, EP Bava, U Vaish, P Sahay, ... HPB 24 (10), 1729-1737, 2022 | 5 | 2022 |
| An immunocompetent model of pancreatic cancer resection and recurrence B Giri, A Ferrantella, P Sharma, T Jain, HKC Jacob, S Modi, S Kurtom, ... Journal of gastrointestinal surgery 25, 1271-1279, 2021 | 5 | 2021 |
| Symphony in chaos: immune orchestra during pancreatic cancer progression P Sharma, T Jain, V Sethi, V Dudeja EBioMedicine 56, 2020 | 4 | 2020 |
| Gut microbiome: the third musketeer in the cancer-immune system cross-talk P Sharma, T Jain, V Sethi, S Iyer, V Dudeja Journal of Pancreatology 3 (4), 181-187, 2020 | 3 | 2020 |
| 439 CIGARETTE SMOKE EXPOSURE PROMOTES CANCER PROGRESSION THROUGH GUT MICROBIAL DYSBIOSIS P Sharma, T Jain, V Sethi, S Kurtom, P Roy, J Tao, B Giri, DB Edwards, ... Gastroenterology (New York, NY 1943) 158 (6), S-1511-S-1512, 2020 | 3 | 2020 |
| Smoke-induced gut microbial dysbiosis promotes cancer progression by creating immunosuppressive tumor microenvironment P Sharma, T Jain, V Sethi, P Roy, S Iyer, J Tao, U Vaish, M Tarique, ... Journal of the American College of Surgeons 231 (4), S280-S281, 2020 | 2 | 2020 |
| Peritoneal Cell-Free DNA: A Novel Biomarker for Recurrence in Pancreatic Cancer A Sickels, T Jain, V Dudeja Annals of Surgical Oncology 30 (11), 6308-6310, 2023 | 1 | 2023 |
| Abstract B038: Toll like receptor 4 (TLR4) agonism by lipopolysaccharide (LPS) in pancreatic cancer model stimulates anti-tumor immunity in CD4+ T cell dependent fashion U Vaish, AR Ferrantella, T Jain, P Sharma, S Iyer, V Dudeja Cancer Research 82 (22_Supplement), B038-B038, 2022 | 1 | 2022 |
| Neoadjuvant therapy alters the biliary microbiome in PDAC T Jain, V Dudeja The American journal of surgery 222 (1), 1-2, 2021 | 1 | 2021 |
| Su303 IL10 is required for the beneficial effect of pirfenidone in mouse models of well-established chronic pancreatitis E Bava, J George, M Tarique, S Iyer, PST Jain, R Dawra, AK Saluja, ... Gastroenterology (New York, NY 1943) 160 (6), S-667-S-667, 2021 | 1 | 2021 |
| Cathepsin B inhibition in the pancreatic stellate cells stimulates CD8+ T cell dependent anti-tumor immune response B Garg, T Jain, U Vaish, V Dudeja Pancreatology 22, e70, 2022 | | 2022 |
| Toll like receptor 4 (TLR4) agonism by lipopolysaccharide (LPS) in pancreatic cancer model stimulates anti-tumor immunity in CD4+ T cell dependent fashion. U Vaish, AR Ferrantella, T Jain, P Sharma, S Iyer, V Dudeja CANCER RESEARCH 82 (22), 82-83, 2022 | | 2022 |
| Hiding in Plain Sight: A Novel Microbial Driver for Colorectal Cancer? T Jain, V Dudeja Cancer Discovery 12 (8), 1838-1840, 2022 | | 2022 |
| A common gut commensal utilizes tryptophan to promote cancer via the aryl hydrocarbon receptor V Sethi, J Tao, S Kurtom, U Vaish, F Afaq, S Zao, X Luo, T Jain, P Sharma, ... Cancer Research 82 (12_Supplement), 3046-3046, 2022 | | 2022 |
